LIMK-IN-22j

CAS No. 1116571-01-7

LIMK-IN-22j( LIMK IN 22j | LIMKIN22j | LIMK inhibitor 22j | LIMK inhibitor-22j )

Catalog No. M27778 CAS No. 1116571-01-7

LIMK-IN-22j is an effective and selective inhibitor of LIMK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 Get Quote
5MG 61 Get Quote
10MG 88 Get Quote
25MG 161 Get Quote
50MG 231 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LIMK-IN-22j
  • Note
    Research use only, not for human use.
  • Brief Description
    LIMK-IN-22j is an effective and selective inhibitor of LIMK.
  • Description
    LIMK-IN-22j is an effective and selective inhibitor of LIMK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LIMK IN 22j | LIMKIN22j | LIMK inhibitor 22j | LIMK inhibitor-22j
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    LIM Kinase (LIMK)
  • Recptor
    tubulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1116571-01-7
  • Formula Weight
    453.34
  • Molecular Formula
    C20H21BrN8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CNC2=NC=NC(N3C[C@H](C)N(/C(NC4=CC=CC(Br)=C4)=N\C#N)CC3)=C21
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gang Li. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities. Eur J Med Chem. 2020 Sep 15;202:112519.
molnova catalog
related products
  • LIMK-IN-22j

    LIMK-IN-22j is an effective and selective inhibitor of LIMK.

  • Shikimic Acid

    Shikimic acid is a tri-hydroxy cyclohexene carboxylic acid important in the biosynthesis of so many compounds that the shikimate pathway is named after it.

  • R-10015

    R-10015 is a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket(IC50 of 38 nM for human LIMK1),and a broad-spectrum antiviral compound for HIV infection.R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?